CG Oncology (CGON) Shares Outstanding (2023 - 2026)

CG Oncology (CGON) has 4 years of Shares Outstanding data on file, last reported at $88.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 15.46% year-over-year to $88.0 million; the trailing twelve-month figure through Mar 2026 stood at $88.0 million (up 15.46% YoY), and the FY2025 full-year result was $80.7 million, up 5.95% from the prior year.
• Shares Outstanding for Q1 2026 stood at $88.0 million, up from $80.7 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $88.0 million in Q1 2026 and bottomed at $3.9 million in Q1 2023.
• The 4-year median for Shares Outstanding is $67.5 million (2024), against an average of $53.4 million.
• The widest annual swing landed in 2024, when Shares Outstanding surged 1627.96%; it then increased 5.95% in 2025.
• A 4-year view of Shares Outstanding shows it stood at $5.2 million in 2023, then surged by 1358.27% to $76.2 million in 2024, then increased by 5.95% to $80.7 million in 2025, then gained by 9.07% to $88.0 million in 2026.
• The last three Shares Outstanding figures came in at $88.0 million (Q1 2026), $80.7 million (Q4 2025), and $78.3 million (Q3 2025), per Business Quant data.

Peer Comparison